Mechanism of substrate transport and inhibition of the human LAT1-4F2hc amino acid transporter

Механизм транспорта субстратов и ингибирования аминокислотного транспортера LAT1–4F2hc человека
Karl‐Heinz Altmann, Qiang Zhou, Yuanyuan Zhang, Jürg Gertsch, Renhong Yan, Xinyue Zhong, Yaning Li, Jennifer Müller, Simon A. Singer, Lu Xia
2021-03-23

LAT1 inhibitorsLAT1-4F2hc transportercryo-EM structuresoutward-facing occluded conformationsubstrate transport
Abstract LAT1 (SLC7A5) is one of the representative light chain proteins of heteromeric amino acid transporters, forming a heterodimer with its heavy chain partner 4F2hc (SLC3A2). LAT1 is overexpressed in many types of tumors and mediates the transfer of drugs and hormones across the blood-brain barrier. Thus, LAT1 is considered as a drug target for cancer treatment and may be exploited for drug delivery into the brain. Here, we synthesized three potent inhibitors of human LAT1, which inhibit transport of leucine with IC50 values between 100 and 250 nM, and solved the cryo-EM structures of the corresponding LAT1-4F2hc complexes with these inhibitors bound at resolution of up to 2.7 or 2.8 Å. The protein assumes an outward-facing occluded conformation, with the inhibitors bound in the classical substrate binding pocket, but with their tails wedged between the substrate binding site and TM10 of LAT1. We also solved the complex structure of LAT1-4F2hc with 3,5-diiodo-l-tyrosine (Diiodo-Tyr) at 3.4 Å overall resolution, which revealed a different inhibition mechanism and might represent an intermediate conformation between the outward-facing occluded state mentioned above and the outward-open state. To our knowledge, this is the first time that the outward-facing conformation is revealed for the HAT family. Our results unveil more important insights into the working mechanisms of HATs and provide a structural basis for future drug design.
1
Cryo-EM structures of LAT1-4F2hc bound to these inhibitors were determined at resolutions up to 2.7–2.8 Å.
2
LAT1-4F2hc adopts an outward-facing occluded conformation with the inhibitors bound, representing the first reported outward-facing conformation for the HAT family.
3
The 3,5-diiodo-L-tyrosine complex reveals a distinct inhibition mechanism and may represent an intermediate between outward-facing occluded and outward-open states.
4
The inhibitors occupy LAT1’s classical substrate-binding pocket, while their tails wedge between the pocket and transmembrane helix 10.
5
These structures provide mechanistic insights into HAT substrate transport and a structural basis for designing LAT1-targeted drugs.
6
Three potent human LAT1 inhibitors were synthesized, inhibiting leucine transport with IC50 values of 100–250 nM.

Human LAT1-4F2hc heteromeric amino acid transporter complexes

The structural mechanisms of substrate transport and inhibitor-mediated inhibition, including conformational states and inhibitor binding modes

Publication Details
Publication Date
2021-03-23
Journal
Publisher
ISSN
Cited by
111
Access Type
Author Information
Authors
Karl‐Heinz Altmann
Qiang Zhou
Yuanyuan Zhang
Jürg Gertsch
Renhong Yan
Xinyue Zhong
Yaning Li
Jennifer Müller
Simon A. Singer
Lu Xia
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%